Trust Co. of Vermont boosted its position in Zimmer Biomet Holdings Inc (NYSE:ZBH) by 3.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,110 shares of the medical equipment provider’s stock after buying an additional 150 shares during the period. Trust Co. of Vermont’s holdings in Zimmer Biomet Holdings were worth $528,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently modified their holdings of ZBH. BlackRock Inc. increased its stake in shares of Zimmer Biomet Holdings by 4,042.4% in the first quarter. BlackRock Inc. now owns 16,740,383 shares of the medical equipment provider’s stock worth $2,044,168,000 after buying an additional 16,336,262 shares during the period. Vanguard Group Inc. increased its stake in shares of Zimmer Biomet Holdings by 3.7% in the first quarter. Vanguard Group Inc. now owns 13,041,411 shares of the medical equipment provider’s stock worth $1,592,488,000 after buying an additional 464,916 shares during the period. State Street Corp increased its stake in shares of Zimmer Biomet Holdings by 2.4% in the first quarter. State Street Corp now owns 8,193,165 shares of the medical equipment provider’s stock worth $1,000,463,000 after buying an additional 191,747 shares during the period. Nordea Investment Management AB increased its stake in shares of Zimmer Biomet Holdings by 25.0% in the first quarter. Nordea Investment Management AB now owns 4,931,281 shares of the medical equipment provider’s stock worth $602,159,000 after buying an additional 987,398 shares during the period. Finally, First Manhattan Co. increased its stake in shares of Zimmer Biomet Holdings by 13.5% in the first quarter. First Manhattan Co. now owns 2,565,370 shares of the medical equipment provider’s stock worth $333,549,000 after buying an additional 305,668 shares during the period. 82.84% of the stock is owned by institutional investors.

Zimmer Biomet Holdings Inc (ZBH) traded down 0.93% during midday trading on Friday, hitting $111.38. 1,036,099 shares of the stock traded hands. The company has a market capitalization of $22.52 billion, a price-to-earnings ratio of 31.72 and a beta of 1.20. The stock’s 50-day moving average price is $122.63 and its 200 day moving average price is $121.15. Zimmer Biomet Holdings Inc has a 52 week low of $95.63 and a 52 week high of $133.49.

Zimmer Biomet Holdings (NYSE:ZBH) last posted its quarterly earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 EPS for the quarter, missing the Zacks’ consensus estimate of $2.10 by $0.02. Zimmer Biomet Holdings had a net margin of 9.42% and a return on equity of 7.31%. The firm had revenue of $1.95 billion for the quarter, compared to the consensus estimate of $1.95 billion. During the same quarter in the prior year, the company earned $2.02 earnings per share. The company’s quarterly revenue was up 1.1% compared to the same quarter last year. On average, equities research analysts predict that Zimmer Biomet Holdings Inc will post $8.24 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 22nd will be issued a $0.24 dividend. The ex-dividend date of this dividend is Thursday, September 21st. This represents a $0.96 annualized dividend and a yield of 0.86%. Zimmer Biomet Holdings’s dividend payout ratio (DPR) is presently 27.59%.

ILLEGAL ACTIVITY NOTICE: “Zimmer Biomet Holdings Inc (ZBH) Position Raised by Trust Co. of Vermont” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this news story on another site, it was illegally copied and republished in violation of international copyright law. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2017/08/19/trust-co-of-vermont-has-528000-position-in-zimmer-biomet-holdings-inc-zbh-updated-updated-updated.html.

ZBH has been the subject of a number of recent analyst reports. Canaccord Genuity reaffirmed a “buy” rating on shares of Zimmer Biomet Holdings in a report on Friday, April 28th. Royal Bank Of Canada upped their price target on shares of Zimmer Biomet Holdings from $133.00 to $140.00 and gave the stock an “outperform” rating in a report on Wednesday, June 21st. Bank of America Corporation reaffirmed a “buy” rating and set a $158.00 price target on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. BidaskClub downgraded shares of Zimmer Biomet Holdings from a “buy” rating to a “hold” rating in a research note on Monday, July 24th. Finally, Piper Jaffray Companies reissued a “buy” rating and issued a $135.00 price objective on shares of Zimmer Biomet Holdings in a research note on Friday, July 28th. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. Zimmer Biomet Holdings has a consensus rating of “Hold” and an average target price of $136.90.

In other Zimmer Biomet Holdings news, insider Sang Yi sold 17,731 shares of the company’s stock in a transaction on Monday, June 12th. The shares were sold at an average price of $124.56, for a total value of $2,208,573.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Tony W. Collins sold 16,986 shares of the company’s stock in a transaction on Monday, July 31st. The stock was sold at an average price of $121.74, for a total transaction of $2,067,875.64. The disclosure for this sale can be found here. 1.07% of the stock is currently owned by corporate insiders.

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Stock Ratings for Zimmer Biomet Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc and related stocks with our FREE daily email newsletter.